The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

JPMorgan's (JPM) 43rd Annual Healthcare Conference kicked off Monday in San Francisco and will continue through January 16, ...

The Justice Department on Monday released special counsel David Weiss' final report on his investigation into Hunter Biden.

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

Trump administrations pro-corporation policies boost healthcare M&A prospects Healthcare investment outlook improves as Trump ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new ...